Dimitra Mihou

Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single‐centre experience in 303 patients

Kostas Zervas, Evgenia Verrou, Zisis Teleioudis et al. · British Journal of Haematology · 2006 · 296 citations

Bone Disease, Zoledronic Acid, Bone Health +12

The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio

Evangelos Terpos, Dimitra Mihou, Richard Szydlo et al. · Leukemia · 2005 · 102 citations

Bone Disease, Hematological Malignancy, Srankl/osteoprotegerin Ratio +9

VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek myeloma study group

Konstantinos Zervas, Dimitra Mihou, Eirini Katodritou et al. · Annals of Oncology · 2007 · 66 citations

Hematological Malignancy, Oncology, Medicine +9

Successful treatment of extramedullary gastric plasmacytoma with the combination of bortezomib and dexamethasone: First reported case

Eirini Katodritou, Charalambos Kartsios, Vassiliki Gastari et al. · Leukemia Research · 2007 · 25 citations

Successful Treatment, Gastroenterology, Surgery +2

Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: The role of albumin in the model

Dimitra Mihou, Eirini Katodritou, Kostas Zervas · Hematology · 2007 · 14 citations · Full text